These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36054111)

  • 1. Atomic Layer Coating to Inhibit Surface Crystallization of Amorphous Pharmaceutical Powders.
    Moseson DE; Benson EG; Nguyen HT; Wang F; Wang M; Zheng K; Narwankar PK; Taylor LS
    ACS Appl Mater Interfaces; 2022 Sep; 14(36):40698-40710. PubMed ID: 36054111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface nanocoating of high drug-loading spray-dried amorphous solid dispersions by atomic layer coating: Excellent physical stability under accelerated storage conditions for two years.
    Van Duong T; Nguyen HT; Wang F; Wang M; Narwankar PK; Taylor LS
    Int J Pharm; 2022 May; 620():121747. PubMed ID: 35427750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Aluminum Oxide Nanocoating on Drug Release from Amorphous Solid Dispersion Particles.
    Moseson DE; Benson EG; Cao Z; Bhalla S; Wang F; Wang M; Zheng K; Narwankar PK; Simpson GJ; Taylor LS
    Mol Pharm; 2023 Jan; 20(1):593-605. PubMed ID: 36346665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin.
    Li Y; Yu J; Hu S; Chen Z; Sacchetti M; Sun CC; Yu L
    Mol Pharm; 2019 Mar; 16(3):1305-1311. PubMed ID: 30668120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of processing on the surface physical stability of amorphous solid dispersions.
    Yang Z; Nollenberger K; Albers J; Moffat J; Craig D; Qi S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):897-908. PubMed ID: 25111184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Physical Stability of Amorphous Drug Formulations via Dry Polymer Coating.
    Capece M; Davé R
    J Pharm Sci; 2015 Jun; 104(6):2076-2084. PubMed ID: 25902736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S; Kestur US; Flaherty DP; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1261-1275. PubMed ID: 32134677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Amorphous Solid Dispersions and Identification of Low Levels of Crystallinity by Transmission Electron Microscopy.
    S'ari M; Blade H; Cosgrove S; Drummond-Brydson R; Hondow N; Hughes LP; Brown A
    Mol Pharm; 2021 May; 18(5):1905-1919. PubMed ID: 33797925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Stability and Dissolution of Amorphous Clofazimine by Polymer Nano-Coating.
    Gui Y; Chen Y; Chen Z; Jones KJ; Yu L
    Pharm Res; 2019 Mar; 36(5):67. PubMed ID: 30877389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine.
    Raula J; Thielmann F; Kansikas J; Hietala S; Annala M; Seppälä J; Lähde A; Kauppinen EI
    Pharm Res; 2008 Oct; 25(10):2250-61. PubMed ID: 18584311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second harmonic generation microscopy as a tool for the early detection of crystallization in spray dried dispersions.
    Correa-Soto C; Trasi NS; Schmitt PD; Su Y; Liu Z; Miller E; Variankaval N; Marsac PJ; Simpson GJ; Taylor LS
    J Pharm Biomed Anal; 2017 Nov; 146():86-95. PubMed ID: 28866472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface Stabilization and Dissolution Rate Improvement of Amorphous Compacts with Thin Polymer Coatings: Can We Have It All?
    Novakovic D; Peltonen L; Isomäki A; Fraser-Miller SJ; Nielsen LH; Laaksonen T; Strachan CJ
    Mol Pharm; 2020 Apr; 17(4):1248-1260. PubMed ID: 32027513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
    Sarpal K; Tower CW; Munson EJ
    Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB; Lodagekar A; Yadav B; Shastri NR
    Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Variability of Physical Properties of Povidone K30 on Crystallization and Drug-Polymer Miscibility of Celecoxib-Povidone K30 Amorphous Solid Dispersions.
    Phadke C; Sharma J; Sharma K; Bansal AK
    Mol Pharm; 2019 Oct; 16(10):4139-4148. PubMed ID: 31454247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.
    Ojo AT; Lee PI
    J Pharm Sci; 2021 Apr; 110(4):1495-1512. PubMed ID: 32818440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Particle Size and Polymer Loading on Dissolution Behavior of Amorphous Griseofulvin Powder.
    Zheng K; Lin Z; Capece M; Kunnath K; Chen L; Davé RN
    J Pharm Sci; 2019 Jan; 108(1):234-242. PubMed ID: 30472263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Polymers on the Drug Solubility and Dissolution Enhancement of Poorly Water-Soluble Rivaroxaban.
    Choi MJ; Woo MR; Choi HG; Jin SG
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.